NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs
January 10, 2022
Portfolio News
Tenaya Therapeutics Provides 2022 Business Updates
January 10, 2022
Escient Pharmaceuticals Appoints Joshua Grass, MBA As CEO
January 5, 2022
Neurona Therapeutics Announces C-Suite Leadership Team
December 13, 2021
